Exelead - Crunchbase Company Profile & Funding

Q: Where is Exelead's headquarters?

Exelead is located in Indianapolis, Indiana, United States.

Overview

Exelead

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

See more interactive data and historical milestones on desktop for the best experience

About Exelead

CB Rank

723840

Exelead is a dynamic platform that develops and produces liposomal and LNP drug product formulations.

Acquired by

Merck KGaA, Darmstadt, Germany

Founded

obfuscation

Private

Indianapolis, Indiana, United States

101-250

www.exeleadbiopharma.com/

Biotechnology

Health Care

Manufacturing

Pharmaceutical

Key People

John P Rigg: CEO

Details

Legal Name

Exelead, Inc.

Operating Status

Closed

Company Type

For Profit

About the Company

Exelead is a dynamic platform that develops and produces liposomal and LNP drug product formulations.

Founded in 2017, the company specializes in manufacturing lipid nanoparticle, liposome, and pegylation formulations.

Exelead is a wholly-owned subsidiary of Essetifin SpA in Rome, Italy—a privately owned pharmaceutical company specializing in

Rare Diseases and Orphan Drugs.

Phone Number

+1 317-347-2800

Predictions & Insights

Growth Insight

See this Growth Insight

Exelead is

Lorem

to be growing

Top Contributing Factors

Merger or Acquisition

Products & Services

Commercial Contract Manufacturing

Exelead offers commercial manufacturing services for sterile products, specializing in complex biological and liposomal formulations, with capabilities for both small and large volume production.

Liposomal & LNP Formulation

Exelead develops and manufactures liposomal and lipid nanoparticle (LNP) formulations for drug delivery, including encapsulation of nucleic acids like siRNA, mRNA, and saRNA.